2 completed, 1 active not recruiting. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
| Phase 2 | 2 | Completed 2 |
Follow NextCell Pharma Ab: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans® ProTrans® - COVID-19 Acute Respiratory Distress Syndrome, Influenza A | Phase 1 | Active not recruiting | NextCell Pharma Ab | 9 | 2021-05-18 | 2025-05-14 |
| Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes ProTrans, Control - Type1diabetes | Phase 1 / Phase 2 | Completed | NextCell Pharma Ab | 15 | 2019-05-17 | 2025-03-07 |
| Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes ProTrans: Allogeneic transplantation with WJMSCs, Placebos - Type1 Diabetes Mellitus | Phase 1 / Phase 2 | Completed | NextCell Pharma Ab | 24 | 2017-11-28 | 2023-04-03 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1)
Transplantation, Homologous (1)
Sweden (3)
Josefine Sundh, MD (1) · Mathias Svahn, PhD (1) · Per-Ola Carlsson, MD, PhD (1) · Per-Ola Carlsson, PhD (1)
2017 (1), 2018 (1)